These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


367 related items for PubMed ID: 7526723

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cytokeratin expression in epithelioid vascular neoplasms.
    Gray MH, Rosenberg AE, Dickersin GR, Bhan AK.
    Hum Pathol; 1990 Feb; 21(2):212-7. PubMed ID: 1689691
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mast cell "densities" in vascular proliferations: a preliminary study of pyogenic granuloma, portwine stain, cavernous hemangioma, cherry angioma, Kaposi's sarcoma, and malignant hemangioendothelioma.
    Hagiwara K, Khaskhely NM, Uezato H, Nonaka S.
    J Dermatol; 1999 Sep; 26(9):577-86. PubMed ID: 10535252
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Staining for factor VIII related antigen and Ulex europaeus agglutinin I (UEA-I) in 230 tumours. An assessment of their specificity for angiosarcoma and Kaposi's sarcoma.
    Leader M, Collins M, Patel J, Henry K.
    Histopathology; 1986 Nov; 10(11):1153-62. PubMed ID: 3100411
    [Abstract] [Full Text] [Related]

  • 11. Ulex europaeus I lectin as a marker for tumors derived from endothelial cells.
    Miettinen M, Holthofer H, Lehto VP, Miettinen A, Virtanen I.
    Am J Clin Pathol; 1983 Jan; 79(1):32-6. PubMed ID: 6401381
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas.
    Poblet E, Gonzalez-Palacios F, Jimenez FJ.
    Virchows Arch; 1996 Jul; 428(4-5):217-21. PubMed ID: 8764929
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms.
    Requena L, Sangueza OP.
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):143-75; quiz 176-8. PubMed ID: 9486670
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma.
    Arai E, Kuramochi A, Tsuchida T, Tsuneyoshi M, Kage M, Fukunaga M, Ito T, Tada T, Izumi M, Shimizu K, Hirose T, Shimizu M.
    J Cutan Pathol; 2006 Jul; 33(7):492-7. PubMed ID: 16872472
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.